These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30820633)

  • 1. Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications.
    Pillinger T; Rogdaki M; McCutcheon RA; Hathway P; Egerton A; Howes OD
    Psychopharmacology (Berl); 2019 Jul; 236(7):1985-1997. PubMed ID: 30820633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study.
    Vingerhoets C; Tse DH; van Oudenaren M; Hernaus D; van Duin E; Zinkstok J; Ramaekers JG; Jansen JF; McAlonan G; van Amelsvoort T
    J Psychopharmacol; 2020 Aug; 34(8):856-863. PubMed ID: 32448020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.
    Bryant JE; Frölich M; Tran S; Reid MA; Lahti AC; Kraguljac NV
    J Psychiatr Res; 2019 Oct; 117():108-115. PubMed ID: 31376621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia.
    McQueen G; Lay A; Lally J; Gabay AS; Collier T; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Psychopharmacology (Berl); 2020 Feb; 237(2):443-451. PubMed ID: 31786651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.
    McQueen G; Lally J; Collier T; Zelaya F; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Psychopharmacology (Berl); 2018 Oct; 235(10):3045-3054. PubMed ID: 30141055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glutamate level and its association with working memory among patients with treatment-resistant schizophrenia (TRS): a proton magnetic resonance spectroscopy study.
    Huang LC; Lin SH; Tseng HH; Chen KC; Abdullah M; Yang YK
    Psychol Med; 2023 May; 53(7):3220-3227. PubMed ID: 35197141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior Cingulate Glutamate and GABA Associations on Functional Connectivity in Schizophrenia.
    Shukla DK; Wijtenburg SA; Chen H; Chiappelli JJ; Kochunov P; Hong LE; Rowland LM
    Schizophr Bull; 2019 Apr; 45(3):647-658. PubMed ID: 29912445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
    Tarumi R; Tsugawa S; Noda Y; Plitman E; Honda S; Matsushita K; Chavez S; Sawada K; Wada M; Matsui M; Fujii S; Miyazaki T; Chakravarty MM; Uchida H; Remington G; Graff-Guerrero A; Mimura M; Nakajima S
    Neuropsychopharmacology; 2020 Mar; 45(4):632-640. PubMed ID: 31842203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.
    Jelen LA; King S; Horne CM; Lythgoe DJ; Young AH; Stone JM
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):222-234. PubMed ID: 30558824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate metabolites in treatment resistant schizophrenia: A meta-analysis and systematic review of
    Kumar V; Manchegowda S; Jacob A; Rao NP
    Psychiatry Res Neuroimaging; 2020 Jun; 300():111080. PubMed ID: 32279055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
    Iwata Y; Nakajima S; Plitman E; Caravaggio F; Kim J; Shah P; Mar W; Chavez S; De Luca V; Mimura M; Remington G; Gerretsen P; Graff-Guerrero A
    Biol Psychiatry; 2019 Apr; 85(7):596-605. PubMed ID: 30389132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects.
    Li M; Woelfer M; Colic L; Safron A; Chang C; Heinze HJ; Speck O; Mayberg HS; Biswal BB; Salvadore G; Fejtova A; Walter M
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):207-216. PubMed ID: 30353262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered functional connectivity in anterior cingulate cortex subregions in treatment-resistant schizophrenia patients.
    Liu Y; Huang H; Qin X; Zheng F; Wang H
    Neurosci Lett; 2023 Sep; 814():137445. PubMed ID: 37597741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
    Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
    Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
    Hjelmervik H; Craven AR; Sinceviciute I; Johnsen E; Kompus K; Bless JJ; Kroken RA; Løberg EM; Ersland L; Grüner R; Hugdahl K
    Schizophr Bull; 2020 Apr; 46(3):633-642. PubMed ID: 31626702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents.
    Lewis CP; Port JD; Frye MA; Vande Voort JL; Ameis SH; Husain MM; Daskalakis ZJ; Croarkin PE
    Front Neural Circuits; 2016; 10():98. PubMed ID: 27965544
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia.
    McQueen G; Sendt KV; Gillespie A; Avila A; Lally J; Vallianatou K; Chang N; Ferreira D; Borgan F; Howes OD; Barker GJ; Lythgoe DJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Schizophr Bull; 2021 Apr; 47(3):662-671. PubMed ID: 33398325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior cingulate glutamate levels associate with functional activation and connectivity during sensory integration in schizophrenia: a multimodal
    Cai XL; Pu CC; Zhou SZ; Wang Y; Huang J; Lui SSY; Møller A; Cheung EFC; Madsen KH; Xue R; Yu X; Chan RCK
    Psychol Med; 2023 Aug; 53(11):4904-4914. PubMed ID: 35791929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.
    Kraguljac NV; Morgan CJ; Reid MA; White DM; Jindal RD; Sivaraman S; Martinak BK; Lahti AC
    Schizophr Res; 2019 Aug; 210():239-244. PubMed ID: 30630705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal trajectories of anterior cingulate glutamate and subclinical psychotic experiences in early adolescence: the impact of bullying victimization.
    Okada N; Yahata N; Koshiyama D; Morita K; Sawada K; Kanata S; Fujikawa S; Sugimoto N; Toriyama R; Masaoka M; Koike S; Araki T; Kano Y; Endo K; Yamasaki S; Ando S; Nishida A; Hiraiwa-Hasegawa M; Edden RAE; Sawa A; Kasai K
    Mol Psychiatry; 2024 Apr; 29(4):939-950. PubMed ID: 38182806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.